Allspring Global Investments Holdings LLC cut its position in shares of National HealthCare Corporation (NYSEAMERICAN:NHC – Free Report) by 15.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 49,535 shares of the company’s stock after selling 8,931 shares during the period. Allspring Global Investments Holdings LLC’s holdings in National HealthCare were worth $7,825,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. Morgan Stanley Institutional Investment Advisors LLC boosted its stake in shares of National HealthCare by 38.6% during the 4th quarter. Morgan Stanley Institutional Investment Advisors LLC now owns 1,038,787 shares of the company’s stock worth $142,407,000 after acquiring an additional 289,566 shares during the period. First Trust Advisors LP raised its stake in National HealthCare by 556.4% in the 3rd quarter. First Trust Advisors LP now owns 207,483 shares of the company’s stock valued at $25,211,000 after acquiring an additional 175,873 shares during the period. Eversept Partners LP bought a new stake in National HealthCare in the 4th quarter valued at $3,918,000. Goldman Sachs Group Inc. lifted its holdings in National HealthCare by 43.5% during the 4th quarter. Goldman Sachs Group Inc. now owns 85,781 shares of the company’s stock valued at $11,760,000 after purchasing an additional 26,020 shares during the last quarter. Finally, Lazard Asset Management LLC lifted its holdings in National HealthCare by 82.2% during the 2nd quarter. Lazard Asset Management LLC now owns 46,647 shares of the company’s stock valued at $4,991,000 after purchasing an additional 21,041 shares during the last quarter. 56.44% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several equities analysts have commented on the stock. Royal Bank Of Canada upgraded shares of National HealthCare to a “hold” rating in a report on Monday, May 18th. The Goldman Sachs Group upgraded shares of National HealthCare to a “strong-buy” rating in a research note on Monday, May 18th. Robert W. Baird upgraded shares of National HealthCare to a “strong-buy” rating in a research note on Monday, May 18th. Finally, BMO Capital Markets upgraded shares of National HealthCare to a “hold” rating in a research note on Monday, May 18th. Two equities research analysts have rated the stock with a Strong Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, National HealthCare has a consensus rating of “Buy”.
Insider Transactions at National HealthCare
In other National HealthCare news, Director Lisa Piercey acquired 949 shares of the business’s stock in a transaction on Monday, June 1st. The stock was purchased at an average price of $184.26 per share, with a total value of $174,862.74. Following the acquisition, the director directly owned 949 shares of the company’s stock, valued at approximately $174,862.74. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 13.92% of the stock is owned by corporate insiders.
National HealthCare Price Performance
NHC stock opened at $221.51 on Friday. National HealthCare Corporation has a fifty-two week low of $93.54 and a fifty-two week high of $232.25. The stock has a market capitalization of $3.46 billion, a price-to-earnings ratio of 28.15 and a beta of 0.63. The business’s fifty day moving average price is $202.45 and its two-hundred day moving average price is $174.86.
National HealthCare (NYSEAMERICAN:NHC – Get Free Report) last announced its earnings results on Thursday, May 7th. The company reported $1.91 earnings per share (EPS) for the quarter. National HealthCare had a net margin of 8.10% and a return on equity of 9.98%. The company had revenue of $381.82 million during the quarter.
National HealthCare Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be paid a $0.67 dividend. This is a positive change from National HealthCare’s previous quarterly dividend of $0.64. The ex-dividend date is Tuesday, June 30th. This represents a $2.68 annualized dividend and a yield of 1.2%. National HealthCare’s dividend payout ratio is presently 61.89%.
About National HealthCare
National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.
Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.
Recommended Stories
- Five stocks we like better than National HealthCare
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Want to see what other hedge funds are holding NHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National HealthCare Corporation (NYSEAMERICAN:NHC – Free Report).
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.
